Categories: Discussion Forum , Funding ethics , News | 1 Comment
[From the March edition of Chemistry World] On 16 January, the Philip Morris Stiftung (‘Foundation’ in English), announced the four winners of its 25th annual research prize, of
25,000 (£17,000) each. The winners were happy, as was Ludwig Maximilians University of Munich (LMU), one of Germany’s top universities. LMU immediately issued a press release touting the fact that one of its professors, biochemist Patrick Cramer, was a winner.
But not everyone was so pleased. Martina Pötschke-Langer, head of the Heidelberg-based German Cancer Research Center (DKFZ), believes scientists should refuse awards like these which are connected to tobacco companies – in this case, Philip Morris International. ‘These scientists are lending their reputations to a company that sells tobacco products that kill people,’ she argues.
Read more about the story here.
How should chemists face ethical questions about funding? Tell us what you think …